Nutra Pharma Corp.
NPHC
$0.0003
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 247.80K | 157.90K | 98.00K | 97.80K | 87.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 247.80K | 157.90K | 98.00K | 97.80K | 87.00K |
| Cost of Revenue | 181.30K | 149.80K | 98.00K | 89.20K | 49.10K |
| Gross Profit | 66.60K | 8.00K | -100.00 | 8.50K | 37.80K |
| SG&A Expenses | 1.45M | 1.67M | 1.76M | 2.00M | 1.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.63M | 1.82M | 1.85M | 2.09M | 1.93M |
| Operating Income | -1.38M | -1.66M | -1.76M | -1.99M | -1.85M |
| Income Before Tax | 7.11M | 21.97M | 25.98M | -13.05M | -17.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 7.11 | 21.97 | 25.98 | -13.05 | -17.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.11M | 21.97M | 25.98M | -13.05M | -17.25M |
| EBIT | -1.38M | -1.66M | -1.76M | -1.99M | -1.85M |
| EBITDA | -1.36M | -1.64M | -1.74M | -1.98M | -1.84M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 29.74B | 29.43B | 29.21B | 28.93B | 28.49B |
| Average Diluted Shares Outstanding | 44.89B | 41.96B | 46.25B | 38.82B | 38.39B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |